(a) Epiflourescent micrographs of Tg(kdrl:GFP) embryos at 38hpf were taken after treatment with DMSO, DMH1 (R-Smad inhibitor), SB203580 (p38 inhibitor), and SL327 (Erk inhibitor). Arrows point to defects in the formation of venous vessels in DMH1- or SL327-treated embryos. (b) The percentage of segments that contain an ISA (red bars) or a CVP (blue bars) was quantified in DMSO (n=14), DMH1 (n=13), SB203580 (n=8), or SL327 (n=10) treated embryos. (c) Confocal depth-code color projections of Tg(hsp70l:bmp2b);Tg(kdrl:GFP) embryos at 46hpf were taken after treatment with small molecule inhibitors. Addition of DMH1 or SL327 to bmp2b over-expressing embryos inhibited Bmp-induced ectopic sprouts. Arrowheads point to ectopic sprouts from the AV. (d) The percentage of segments that contain an ectopic vessel was quantified in DMSO (n=11), DMH1 (n=13), SB203580 (n=4), or SL327 (n=6) treated embryos. (e) The average ectopic vessel length was quantified in DMSO (n=15), DMH1 (n=14), SB203580 (n=16), or SL327 (n= 22) treated embryos. Inhibition of either R-Smad or Erk activation significantly reduced the formation ectopic vessels and the average length of ectopic vessels. Error bars represent mean ± SEM. **P<0.01 and ***P<0.001 versus control, Student’s t test.